Nanomedicine, Volume IIA: Biocompatibility
© 2003 Robert A. Freitas Jr. All Rights Reserved.
Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003
6100. U. Schroeder, P. Sommerfeld, B.A. Sabel, “Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier,” Peptides 19(1998):777-780.
6101. U. Schroeder, P. Sommerfeld, S. Ulrich, B.A. Sabel, “Nanoparticle technology for delivery of drugs across the blood-brain barrier,” J. Pharm. Sci. 87(November 1998):1305-1307.
6102. A.E. Gulyaev, S.E. Gelperina, I.N. Skidan, A.S. Antropov, G.Y. Kivman, J. Kreuter, “Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles,” Pharm. Res. 16(October 1999):1564-1569.
6103. A. Friese, E. Seiller, G. Quack, B. Lorenz, J. Kreuter, “Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system,” Eur. J. Pharm. Biopharm. 49(March 2000):103-109.
6104. R.N. Alyautdin, V.E. Petrov, K. Langer, A. Berthold, D.A. Kharkevich, J. Kreuter, “Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles,” Pharm. Res. 14(March 1997):325-328.
6105. R.N. Alyautdin, E.B. Tezikov, P. Ramge, D.A. Kharkevich, D.J. Begley, J. Kreuter, “Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study,” J. Microencapsul. 15(January-February 1998):67-74.
6106. S. Yang, J. Zhu, Y. Lu, B. Liang, C. Yang, “Body distribution of camptothecin solid lipid nanoparticles after oral administration,” Pharm. Res. 16(May 1999):751-757.
6107. J.X. Wang, X. Sun, Z.R. Zhang, “Enhanced brain targeting by synthesis of 3’,5’-dioctanoyl-5-fluoro-2’-deoxyuridine and incorporation into solid lipid nanoparticles,” Eur. J. Pharm. Biopharm. 54(November 2002):285-290.
6108. A. Bargoni, R. Cavalli, G.P. Zara, A. Fundaro, O. Caputo, M.R. Gasco, “Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution,” Pharmacol. Res. 43(May 2001):497-502.
6109. G.P. Zara, A. Bargoni, R. Cavalli, A. Fundaro, D. Vighetto, M.R. Gasco, “Pharmacokinetics and tissue distribution of idarubicin-loaded solid lipid nanoparticles after duodenal administration to rats,” J. Pharm. Sci. 91(May 2002):1324-1333.
6110. C. Olbrich, A. Gessner, O. Kayser, R.H. Muller, “Lipid-drug-conjugate (LDC) nanoparticles as novel carrier system for the hydrophilic antitrypanosomal drug diminazenediaceturate,” J. Drug Target. 10(August 2002):387-396.
6111. P. Calvo, B. Gouritin, H. Chacun, D. Desmaele, J. D’Angelo, J.P. Noel, D. Georgin, E. Fattal, J.P. Andreux, P. Couvreur, “Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery,” Pharm. Res. 18(August 2001):1157-1166.
6112. L. Fenart, A. Casanova, B. Dehouck, C. Duhem, S. Slupek, R. Cecchelli, D. Betbeder, “Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier,” J. Pharmacol. Exp. Ther. 291(December 1999):1017-1022; http://jpet.aspetjournals.org/cgi/content/full/291/3/1017
6113. S.I. Rapoport, “Osmotic opening of the blood-brain barrier,” Ann. Neurol. 24(November 1988):677-684.
6114. M.W. Brightman, M. Hori, S.I. Rapoport, T.S. Reese, E. Westergaard, “Osmotic opening of tight junctions in cerebral endothelium,” J. Comp. Neurol. 152(1973):317-326.
6115. S.I. Rapoport, P.J. Robinson, “Tight-junctional modification as the basis of osmotic opening of the blood-brain barrier,” Ann. N.Y. Acad. Sci. 481(1986):250-267.
6116. V. Rousseau, B. Denizot, D. Pouliquen, P. Jallet, J.J. Le Jeune, “Investigation of blood-brain barrier permeability to magnetite-dextran nanoparticles (MD3) after osmotic disruption in rats,” MAGMA 5(September 1997):213-222.
6117. Leslie L. Muldoon, Michael A. Pagel, Robert A. Kroll, Simon Roman-Goldstein, Russell S. Jones, Edward A. Neuwelt, “A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery,” AJNR Am. J. Neuroradiol. 20(February 1999):217-222; http://www.ajnr.org/cgi/content/full/20/2/217
6118. L.L. Muldoon, G. Nilaver, R.A. Kroll, M.A. Pagel, X.O. Breakefield, E.A. Chiocca, B.L. Davidson, R. Weissleder, E.A. Neuwelt, “Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain,” Am. J. Pathol. 147(1995):1840-1851.
6119. S.E. Doran, X.D. Ren, A.L. Betz, M.A. Pagel, E.A. Neuwelt, B.J. Roessler, B.L. Davidson, “Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption,” Neurosurgery 36(May 1995):965-970.
6120. G. Nilaver, L.L. Muldoon, R.A. Kroll, M.A. Pagel, X.O. Breakefield, B.L. Davidson, E.A. Neuwelt, “Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption,” Proc. Natl. Acad. Sci. (USA) 92(1995):9829-9833; http://www.pnas.org/cgi/content/abstract/92/21/9829
6121. E.A. Neuwelt, M.A. Pagel, R.D. Dix, “Delivery of ultraviolet-inactivated 35S-herpesvirus across an osmotically modified blood-brain barrier,” J. Neurosurg. 74(March 1991):475-479.
6122. T. Shen, R. Weissleder, M. Papisov, A. Bogdanov Jr., T.J. Brady, “Monocrystalline iron oxide nanocompounds (MION): physicochemical properties,” Magn. Reson. Med. 29(May 1993):599-604.
6123. Millipore Corp., Viresolve Virus Clearance Selection Guide, 2003; http://www.millipore.com/biopharm/products.nsf/docs/viresolveselector
6124. T. Inamura, T. Nomura, R.T. Bartus, K.L. Black, “Intracarotid infusion of RMP-7, a bradykinin analog: A method for selective drug delivery to brain tumors,” J. Neurosurg. 81(November 1994):752-758.
6125. R.A. Kroll, M.A. Pagel, L.L. Muldoon, S. Roman-Goldstein, S.A. Fiamengo, E.A. Neuwelt, “Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers,” Neurosurgery 43(October 1998):879-886, 886-889 (discussion). Comment in: B.V. Zlokovic, M.L. Apuzzo, “Strategies to circumvent vascular barriers of the central nervous system,” Neurosurgery 43(October 1998):877-878.
6126. M. Merodio, J.M. Irache, F. Eclancher, M. Mirshahi, H. Villarroya, “Distribution of albumin nanoparticles in animals induced with the experimental allergic encephalomyelitis,” J. Drug Target. 8(2000):289-303.
6127. P. Calvo, B. Gouritin, H. Villarroya, F. Eclancher, C. Giannavola, C. Klein, J.P. Andreux, P. Couvreur, “Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat,” Eur. J. Neurosci. 15(April 2002):1317-1326.
6128. Y. Persidsky, M. Stins, D. Way, M.H. Witte, M. Weinand, K.S. Kim, P. Bock, H.E. Gendelman, M. Fiala, “A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis,” J. Immunol. 158(1 April 1997):3499-3510.
6129. V.J. Quagliarello, A. Ma, H. Stukenbrok, G.E. Palade, “Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat,” J. Exp. Med. 174(1 September 1991):657-672.
6130. H. Wolburg, A. Lippoldt, “Tight junctions of the blood-brain barrier: development, composition and regulation,” Vascul. Pharmacol. 38(June 2002):323-337.
6131. J. Greenwood, S. Etienne-Manneville, P. Adamson, P.O. Couraud, “Lymphocyte migration into the central nervous system: implication of ICAM-1 signaling at the blood-brain barrier,” Vascul. Pharmacol. 38(June 2002):315-322.
6132. M.A. Bogoyevitch, T.S. Kendrick, D.C. Ng, R.K. Barr, “Taking the cell by stealth or storm? Protein transduction domains (PTDs) as versatile vectors for delivery,” DNA Cell Biol. 21(December 2002):879-894.
6133. P.A. Stewart, M. Magliocco, K. Hayakawa, C.L. Farrell, R.F. Del Maestro, J. Girvin, J.C. Kaufmann, H.V. Vinters, J. Gilbert, “A quantitative analysis of blood-brain barrier ultrastructure in the aging human,” Microvasc. Res. 33(March 1987):270-282.
6134. P.A. Fraser, A.D. Dallas, “Permeability of disrupted cerebral microvessels in the frog,” J. Physiol. 461(February 1993):619-632.
6135. A.W. Vorbrodt, D.H. Dobrogowska, M. Tarnawski, A.S. Lossinsky, “A quantitative immunocytochemical study of the osmotic opening of the blood-brain barrier to endogenous albumin,” J. Neurocytol. 23(December 1994):792-800.
6136. A. Ermisch, H.J. Ruhle, R. Landgraf, J. Hess, “Blood-brain barrier and peptides,” J. Cereb. Blood Flow Metab. 5(September 1985):350-357.
6137. W.G. Mayhan, F.M. Faraci, D.D. Heistad, “Disruption of the blood-brain barrier in cerebrum and brain stem during acute hypertension,” Am. J. Physiol. 251(December 1986):H1171-H1175.
6138. T.L. Kemper, G.J. Blatt, R.J. Killiany, M.B. Moss, “Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys,” Acta Neuropathol. (Berl.) 101(February 2001):145-153.
6139. A.W. Vorbrodt, D.H. Dobrogowska, “Interaction of glycated albumin-gold complexes with mouse brain microvascular endothelium,” Folia Histochem. Cytobiol. 37(1999):3-10.
6140. P.C. Bragt, I.L. Bonta, M.J. Adolfs, “Cannulated teflon chamber implant in the rat: a new model for continuous studies on granulomatous inflammation,” J. Pharmacol. Methods 3(January 1980):51-61.
6141. L. Strukelj, “Research on the carcinomatous and granulomatous pocket. II. Diffusion of tetracycline in the carcinomatous and granulomatous pockets,” Friuli Med. 20(November-December 1965):923-928. In Italian.
6142. A. Wohlman, M. Syed, S. Avakian, “Enhancement of drug activity by chymotrypsin. Penicillin penetration into granulomatous lesions and inflammatory fluids,” Experientia 25(15 September 1969):953-954.
6143. I.Ia. Geitman, G.Ia. Kivman, N.A. Kalinina, I.R. Balyn’, L.V. Butylina, “Pharmacokinetics of penicillins in the body of rats, including penetration into a granuloma, with repeated administration of the antibiotics and chymotrypsin,” Antibiotiki 19(November 1974):1012-1017 (in Russian); I.Ia. Geitman, G.Ia. Kivman, N.A. Kalinina, I.R. Balyn’, “The pharmacokinetics of kanamycin, including granuloma penetration, in rats treated with chymotrypsin,” Antibiotiki 18(November 1973):1016-1020 (in Russian).
6144. Y. Akimoto, H. Nishimura, M. Komiya, K. Kaneko, A. Fujii, T. Tamura, “Ampicillin concentrations in human dental granuloma after a single oral administration of talampicillin,” Antimicrob. Agents Chemother. 32(April 1988):566-567; A. Uda, H. Omata, J. Shibutani, H. Nishimura, M. Komiya, Y. Akimoto, K. Kaneko, A. Fujii, “Josamycin concentrations in human dental granuloma after a single oral administration of josamycin,” Gen. Pharmacol. 20(1989):823-825; Y. Akimoto, K. Kaneko, A. Fujii, H. Yamamoto, “Ampicillin concentrations in human radicular granuloma following a single oral dose of bacampicillin,” J. Oral Maxillofac. Surg. 50(January 1992):11-13; Y. Akimoto, Y. Mochizuki, A. Uda, H. Omata, S. Saito, K. Kaneko, A. Fujii, H. Yamamoto, “Josamycin concentrations in radicular cysts following a single oral administration,” Gen. Pharmacol. 24(January 1993):143-145; Y. Akimoto, Y. Mochizuki, A. Uda, J. Shibutani, H. Nishimura, M. Komiya, K. Kaneko, A. Fujii, H. Yamamoto, “Ampicillin concentrations in radicular cysts following a single oral administration of bacampicillin,” Gen. Pharmacol. 24(July 1993):895-898; Y. Akimoto, Y. Mochizuki, A. Uda, H. Omata, J. Shibutani, H. Nishimura, M. Komiya, K. Kaneko, T. Kawana, A. Fujii, et al, “Concentrations of lomefloxacin in radicular cyst and oral tissues following single or multiple oral administration,” J. Nihon Univ. Sch. Dent. 35(December 1993):267-275; Y. Akimoto, A. Uda, H. Omata, J. Shibutani, H. Nishimura, M. Komiya, T. Kawana, K. Kaneko, A. Fujii, T. Kaneda, et al, “Cephalexin concentrations in radicular granuloma following a single oral administration of 250- or 500-mg cephalexin,” Gen. Pharmacol. 25(December 1994):1563-1566; Y. Akimoto, M. Ikeda, H. Omata, J. Shibutani, A. Fujii, T. Kaneda, H. Yamamoto, T. Takato, “Cefaclor concentration in radicular granuloma after a single oral administration,” Gen. Pharmacol. 31(August 1998):283-285.
6145. S. Yagishita, Y. Itoh, T. Nakano, Y. Ono, N. Amano, “Crystalloid inclusions reminiscent of Hirano bodies in autolyzed peripheral nerve of normal Wistar rats,” Acta Neuropathol (Berl.) 47(August 1979):231-236.
6146. L. Weiss, R. Zeigel, O.S. Jung, I.D. Bross, “Binding of positively charged particles to glutaraldehyde-fixed human erythrocytes,” Exp. Cell Res. 70(1972):57-64.
6147. D.L. Schotland, S. DiMauro, E. Bonilla, A. Scarpa, C.P. Lee, “Neuromuscular disorder associated with a defect in mitochondrial energy supply,” Arch. Neurol. 33(July 1976):475-479.
6148. G.W. Farrants, S. Hovmoller, A.M. Stadhouders, “Two types of mitochondrial crystals in diseased human skeletal muscle fibers,” Muscle Nerve 11(January 1988):45-55.
6149. N.G. Ryley, R. Forman, D. Barlow, K.A. Fleming, J.M. Trowell, “Liver abnormality in ovarian hyperstimulation syndrome,” Hum. Reprod. 5(November 1990):938-943.
6150. E. O’Gorman, T. Piendl, M. Muller, D. Brdiczka, T. Wallimann, “Mitochondrial intermembrane inclusion bodies: the common denominator between human mitochondrial myopathies and creatine depletion, due to impairment of cellular energetics,” Mol. Cell Biochem. 174(September 1997):283-289.
6151. K. Matsumuro, S. Izumo, Y. Minauchi, M. Inose, I. Higuchi, M. Osame, “Chronic demyelinating neuropathy and intra-axonal polyglucosan bodies,” Acta Neuropathol. (Berl.) 86(1993):95-99.
6152. C. Vital, S. Bouillot, M.H. Canron, A. Vital, “Schwannian crystalline-like inclusions bodies (Fardeau-Engel bodies) revisited in peripheral neuropathies,” Ultrastruct. Pathol. 26(January-February 2002):9-13.
6153. J. Pan, C. Leygraf, D. Thierry, A.M. Ektessabi, “Corrosion resistance for biomaterial applications of TiO2 films deposited on titanium and stainless steel by ion-beam-assisted sputtering,” J. Biomed. Mater. Res. 35(5 June 1997):309-318.
6154. A. Nanci, J.D. Wuest, L. Peru, P. Brunet, V. Sharma, S. Zalzal, M.D. McKee, “Chemical modification of titanium surfaces for covalent attachment of biological molecules,” J. Biomed. Mater. Res. 40(May 1998):324-335.
6155. C. Yongli, Z. Xiufang, G. Yandao, Z. Nanming, Z. Tingying, S. Xinqi, “Conformational changes of fibrinogen adsorption onto hydroxyapatite and titanium oxide nanoparticles,” J. Colloid Interface Sci. 214(1 June 1999):38-45.
6156. S.Y. Kwak, S.H. Kim, S.S. Kim, “Hybrid organic/inorganic reverse osmosis (RO) membrane for bactericidal anti-fouling. 1. Preparation and characterization of TiO2 nanoparticle self-assembled aromatic polyamide thin-film-composite (TFC) membrane,” Environ. Sci. Technol. 35(1 June 2001):2388-2394.
6157. P.A. Ramires, A. Romito, F. Cosentino, E. Milella, “The influence of titania/hydroxyapatite composite coatings on in vitro osteoblast behaviour,” Biomaterials 22(June 2001):1467-1474.
6158. F.Y. Oliva, L.B. Avalle, V.A. Macagno, C.P. De Pauli, “Study of human serum albumin-TiO(2) nanocrystalline electrodes interaction by impedance electrochemical spectroscopy,” Biophys. Chem. 91(2 July 2001):141-155.
6159. T. Sawase, A. Wennerberg, K. Baba, Y. Tsuboi, L. Sennerby, C.B. Johansson, T. Albrektsson, “Application of oxygen ion implantation to titanium surfaces: effects on surface characteristics, corrosion resistance, and bone response,” Clin. Implant Dent. Relat. Res. 3(2001):221-229.
6160. M. Manso, S. Ogueta, P. Garcia, J. Perez-Rigueiro, C. Jimenez, J.M. Martinez-Duart, M. Langlet, “Mechanical and in vitro testing of aerosol-gel deposited titania coatings for biocompatible applications,” Biomaterials 23(January 2002):349-356.
6161. D.E. MacDonald, N. Deo, B. Markovic, M. Stranick, P. Somasundaran, “Adsorption and dissolution behavior of human plasma fibronectin on thermally and chemically modified titanium dioxide particles,” Biomaterials 23(February 2002):1269-1279.
6162. K.R. Meier, M. Gratzel, “Redox targeting of oligonucleotides anchored to nanocrystalline TiO2 films for DNA detection,” Chemphyschem 3(15 April 2002):371-374.
6163. J. Pan, G. Benko, Y. Xu, T. Pascher, L. Sun, V. Sundstrom, T. Polivka, “Photoinduced electron transfer between a carotenoid and TiO2 nanoparticle,” J. Am. Chem. Soc. 124(20 November 2002):13949-13957.
6164. T. Paunesku, T. Rajh, G. Wiederrecht, J. Maser, S. Vogt, N. Stojicevic, M. Protic, B. Lai, J. Oryhon, M. Thurnauer, G. Woloschak, “Biology of TiO(2)-oligonucleotide nanocomposites,” Nat. Mater. 2(May 2003):343-346.
6165. H. Kong, J.L. Wilkinson, J.Y. Coe, X. Gu, M. Urness, T.H. Kim, J.L. Bass, “Corrosive behaviour of Amplatzer devices in experimental and biological environments,” Cardiol. Young 12(May 2002):260-265.
6166. M. Hannuksela, J. Hassi, “Hairdresser’s hand,” Derm. Beruf. Umwelt 28(1980):149-151.
6167. D.J. Hogan, “Subungual trichogranuloma in a hairdresser,” Cutis 42(August 1988):105-106.
6168. M.R. Patel, L. Bassini, R. Nashad, M.T. Anselmo, “Barber’s interdigital pilonidal sinus of the hand: a foreign body hair granuloma,” J. Hand Surg. 15(July 1990):652-655.
6169. S. Kremmer, J.M. Rohrbach, A. Frohn, A. Eckstein, H.J. Thiel, “Tarantule hairs as corneal foreign bodies,” Klin. Monatsbl. Augenheilkd. 206(April 1995):277-278. In German.
6170. Joseph Mendel Yoffey, Frederick Colin Courtice, Lymphatics, Lymph and the Lymphomyeloid Complex, Academic Press, New York, 1970.
6171. Bjorn E.W. Nordenstrom, “An additional circulatory system: Vascular-Interstitial Closed Electric Circuits (VICC),” J. Biol. Phys. 15(1987):43-55.
6172. Steven M. Block, Charles L. Asbury, Joshua W. Shaevitz, M.J. Lang, “Probing the kinesin reaction cycle with a 2D optical force clamp,” Proc. Natl. Acad. Sci. (USA) 100(4 March 2003):2351-2356.
6173. A. Rolland, N. Wagner, A. Chatelus, B. Shroot, H. Schaefer, “Site-specific drug delivery to pilosebaceous structures using polymeric microspheres,” Pharm. Res. 10(December 1993):1738-1744.
6174. Sally S. Tinkle, James M. Antonini, Brenda A. Rich, Jenny R. Roberts, Rebecca Salmen, Karyn DePree, Eric J. Adkins, “Skin as a route of exposure and sensitization in chronic beryllium disease,” Environ. Health Perspect. doi:10.1289/ehp.5999 (available at http://dx.doi.org/), online 24 February 2003; http://ehpnet1.niehs.nih.gov/docs/2003/5999/abstract.pdf (abstract)
6175. J. Lademann, N. Otberg, H. Richter, H.J. Weigmann, U. Lindemann, H. Schaefer, W. Sterry, “Investigation of follicular penetration of topically applied substances,” Skin. Pharmacol. Appl. Skin Physiol. 14(2001):17-22; J. Lademann, H.J. Weigmann, C. Rickmeyer, H. Barthelmes, H. Schaefer, G. Mueller, W. Sterry, “Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice,” Skin. Pharmacol. Appl. Skin Physiol. 12(September-October 1999):247-256.
6176. H. Yildirim Erbil, A. Levent Demirel, Yonca Avci, Olcay Mert, “Transformation of a simple plastic into a superhydrophobic surface,” Science 299(28 February 2003):1377-1380.
6177. W.G. Kreyling, M. Semmler, F. Erbe, P. Mayer, S. Takenaka, H. Schultz, G. Oberdorster, A. Ziesenis, “Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low,” J. Toxicol. Environ. Health A 65(25 October 2002):1513-1530.
6178. G. Oberdorster, Z. Sharp, V. Atudorei, A. Elder, R. Gelein, A. Lunts, W. Kreyling, C. Cox, “Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats,” J. Toxicol. Environ. Health A 65(25 October 2002):1531-1543.
6179. J.D. Eakins, A.E. Lally, “The transfer to land of actinide bearing sediments from the Irish Sea by spray,” Sci. Total Environ. 35(1984):23-32.
6180. B. Yurke, A.J. Turberfield, A.P. Mills, Jr., F.C. Simmel, J.L. Neumann, “A DNA-fuelled molecular machine made of DNA,” Nature 406(10 August 2000):605-608; http://www.nature.com/nsu/000810/000810-10.html
6181. Friedrich C. Simmel, Bernard Yurke, “Using DNA to construct and power a nanoactuator,” Phys. Rev. E 63(April 2001):041913.
6182. Friedrich C. Simmel, Bernard Yurke, “A DNA-based molecular device switchable between three distinct mechanical states,” Appl. Phys. Lett. 80(4 February 2002):883-885; http://www.ee.sc.edu/research/moletronics/teaching/MolecularElectronics2003/Homework_files/homework6_files/groupe2.pdf
6183. Commission on Life Sciences (CLS), Toxicity of Military Smokes and Obscurants, Vol. 2, National Academies Press, 1999, pp. 68-96.
6184. Rosemary Dunford, Angela Salinaro, Lezhen Cai, Nick Serpone, Satoshi Horikoshi, Hisao Hidaka, John Knowland, “Chemical oxidation and DNA damage catalysed by inorganic sunscreen ingredients,” FEBS Lett. 418(24 November 1997):87-90.
6185. N. Serpone, A. Salinaro, A.V. Emeline, S. Horikoshi, H. Hidaka, J. Zhao, “An in vitro systematic spectroscopic examination of the photostabilities of a random set of commercial sunscreen lotions and their chemical UVB/UVA active agents,” Photochem. Photobiol. Sci. 1(December 2002):970-981.
6186. W.G. Wamer, J.J. Yin, R.R.Wei, “Oxidative damage to nucleic acids photosensitized by titanium dioxide,” Free Radic. Biol. Med. 23(1997):851-858.
6187. M. Rouabhia, D.L. Mitchell, M. Rhainds, J. Claveau, R. Drouin, “A physical sunscreen protects engineered human skin against artificial solar ultraviolet radiation-induced tissue and DNA damage,” Photochem. Photobiol. Sci. 1(July 2002):471-477.
6188. C. Vyvyan Howard, “Nano-particles and Toxicity,” 2 April 2003; http://etcgroup.org/documents/Occ.Paper_Nanosafety.pdf
6189. M. Gumbleton, “Caveolae as potential macromolecule trafficking compartments within alveolar epithelium,” Adv. Drug Delivery Rev. 49(28 July 2001):281-300.
6190. K. Donaldson, V. Stone, P.S. Gilmour, D.M. Brown, W. MacNee, “Ultrafine particles: mechanisms of lung injury,” Phil. Trans. Roy. Soc. Lond. 358(2000):2741-2749.
6191. J. Donaldson, V. Stone, W. MacNee, “The toxicology of ultrafine particles,” in C.V. Howard, R.L. Maynard, eds., Particulate Matter: Properties and Effects Upon Health, BIOS Scientific Publishers Ltd. (Oxford), Springer (New York), 1999, pp. 115-129.
6192. G. Oberdorster, “Toxicology of ultrafine particles: in vivo studies,” Phil. Trans. R. Soc. Lond. 358(2000):2719-2740.
6193. J. Donaldson, V. Stone, A. Clouter, L. Renwick, W. MacNee, “Ultrafine particles,” Occup. Environ. Med. 58(March 2001):211-216.
6194. K. Donaldson, D. Brown, A. Clouter, R. Duffin, W. MacNee, L. Renwick, L. Tran, V. Stone, “The pulmonary toxicology of ultrafine particles,” J. Aerosol Med. 15(Summer 2002):213-220.
6195. C.A. Dick, D.M. Brown, K. Donaldson, V. Stone, “The role of free radicals in the toxic and inflammatory effects of four different ultrafine particle types,” Inhal. Toxicol. 15(January 2003):39-52.
6196. A.L. Lambert, J.B. Mangum, M.P. DeLorme, J.L. Everitt, “Ultrafine carbon black particles enhance respiratory syncytial virus-induced airway reactivity, pulmonary inflammation, and chemokine expression,” Toxicol. Sci. 72(April 2003):339-346.
6197. A. Seaton, W. MacNee, K. Donaldson, D. Godden, “Particulate air pollution and acute health effects,” Lancet 345(21 January 1995):176-178.
6198. A. Nemmar, M.F. Hoylaerts, P.H. Hoet, J. Vermylen, B. Nemery, “Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis,” Toxicol. Appl. Pharmacol. 186(1 January 2003):38-45.
6199. N. Li, C. Sioutas, A. Cho, D. Schmitz, C. Misra, J. Sempf, M. Wang, T. Oberley, J. Froines, A. Nel, “Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage,” Environ. Health Perspect. 111(April 2003):455-460.
Last updated on 16 April 2004